Thales Paulo Batista

Thales Paulo Batista

Auto-generated profile, based on publicly available information

Thales Paulo Batista

Department of Surgery Universidade Federal de Pernambuco (UFPE) Recife Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
TBT.P. Batista
T.P. Batista
CCC.L.C. Cavalcanti
C.L.C. Cavalcanti
ATA.A.G. Tejo
A.A.G. Tejo
ABA.L.R. Bezerra
A.L.R. Bezerra

25 January 2023 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
VCVandré Cabral Gomes Carneiro
Vandré Cabral Gomes Carneiro
TBThales Paulo Batista
Thales Paulo Batista
MAManoel Rodrigues Andrade
Manoel Rodrigues Andrade
ABAldo Vieira Barros
Aldo Vieira Barros
LCLuciana Holanda Lima Dornelas Câmara
Luciana Holanda Lima Dornelas Câmara
GBGlauco Baiocchi
Glauco Baiocchi
Objective To evaluate the non-inferiority and safety of simple hysterectomy in early stage (<2 cm) cervical cancer. Methods This proof-of-concept randomized phase II non-inferiority trial was performed between May 2015 and April 2018 in three oncological centers in Northeast Brazil. Patients with International Federation of Gynecology and Obstetrics (FIGO) 2009 stages IA2–IB1 cervical cancer and tumors ≤2 cm were treated with either simple or modified radical hysterectomy (Querleu–Morrow type B2). Intention-to-treat analysis was carried out. The primary endpoint was 3-year disease-free survival and secondary endpoints were overall survival, operative outcomes, adjuvant therapy, and patient’s health-related quality of life (QoL). Results A total of 40 patients underwent either simple hysterectomy (n=20) or modified radical hysterectomy (n=20). All patients except three underwent open procedures (n=37/40, 92.5%). At a median follow-up of 52.1 months (IQR 43.9–60.1), 3-year disease-free survival was 95% (95% CI 68% to 99%) after simple hysterectomy and 100% (95% CI 100% to 100%) after modified radical hysterectomy (log-rank p=0.30). The corresponding 5-year overall survival rates were 90% (95% CI 64% to 97%) and 91% (95% CI 50% to 98%), respectively (log-rank p=0.46). The operative time was shorter after simple hysterectomy than after modified radical hysterectomy (150 min (IQR 137.5–180) vs 199.5 min (IQR 140–230); p=0.003), with a trend towards a longer time for vesical catheterization removal (1 day (IQR 1–1) vs 1 day (IQR 1–2); p=0.043). There was no post-operative mortality and the rates of post-operative complications were not statistically different between arms (15% and 25%; p=0.69). QoL questionnaires were received from only 17 patients (42.5%), with no major differences observed over time between the surgical arms. Conclusions Simple hysterectomy is safe and potentially non-inferior to the radical surgery in patients with early-stage cervical cancer ≤2 cm. Trial Registration number NCT02613286.

1 January 2011 in Clinics
Verified
Journal Article
Open access
PDF file
TBThales Paulo Batista
Thales Paulo Batista
BSBernardo David Sabat
Bernardo David Sabat
PMPaulo Sérgio V. Melo
Paulo Sérgio V. Melo
LMLuiz Eduardo C. Miranda
Luiz Eduardo C. Miranda
OFOlival Cirilo L. Fonseca-Neto
Olival Cirilo L. Fonseca-Neto
CLCláudio Moura Lacerda
Cláudio Moura Lacerda
To analyze the impact of model for end-stage liver disease (MELD) allocation policy on survival outcomes after liver transplantation (LT). Considering that an ideal system of grafts allocation should also ensure improved survival after transplantation, changes in allocation policies need to be evaluated in different contexts as an evolutionary process. A retrospective cohort study was carried out among patients who underwent LT at the University of Pernambuco. Two groups of patients transplanted before and after the MELD allocation policy implementation were identified and compared using early postoperative mortality and post-LT survival as end-points. Overall, early postoperative mortality did not significantly differ between cohorts (16.43% vs. 8.14%; p = 0.112). Although at 6 and 36-months the difference between pre-vs. post-MELD survival was only marginally significant (p = 0.066 and p = 0.063; respectively), better short, medium and long-term post-LT survival were observed in the post-MELD period. Subgroups analysis showed special benefits to patients categorized as nonhepatocellular carcinoma (non-HCC) and moderate risk, as determined by MELD score (15-20). This study ensured a more robust estimate of how the MELD policy affected post-LT survival outcomes in Brazil and was the first to show significantly better survival after this new policy was implemented. Additionally, we explored some potential reasons for our divergent survival outcomes. Better survival outcomes were observed in this study after implementation of the MELD criterion, particularly amongst patients categorized as non-HCC and moderate risk by MELD scoring. Governmental involvement in organ transplantation was possibly the main reason for improved survival.


1 September 2015 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
EMEuclides Dias Martins-Filho
Euclides Dias Martins-Filho
TBThales Paulo Batista
Thales Paulo Batista
FKFlávio Kreimer
Flávio Kreimer
AMAntonio Cavalcanti de Albuquerque Martins
Antonio Cavalcanti de Albuquerque Martins
TITiago Cavalcanti Iwanaga
Tiago Cavalcanti Iwanaga
CLCristiano de Souza Leão
Cristiano de Souza Leão
BackgroundGallbladder cancer is sometimes incidentally uncovered following cholecystectomy for gallstones diseases. The supposed highly variable prevalence of incidental gallbladder cancer through our country is unknown.ObjectiveTo explore the prevalence of incidental gallbladder cancer in our tertiary-care hospital.MethodsA cross-sectional study was carried out on patients who consecutively underwent cholecystectomy due to gallstones disease at Faculdade Pernambucana de Saúde, Instituto de Medicina Integral Professor Fernando Figueira - FPS/IMIP, from January, 2007 to December, 2010. Data on incidental gallbladder cancer patients were explored for prevalence estimation and description of our experience with the management of this malignancy.ResultsOur analysis involved 2018 patients with a marked predominance of women (n=1.697; 84.1%) over men (n=321; 15.9%). The 3-year prevalence estimate of 0.34% was recorded for incidental gallbladder cancer in our sample. Regarding tumor staging, there were 1 T1a, 1 T1b, and 5 T2 adenocarcinoma tumors. Laparoscopic cholecystectomy alone was performed for the T1a tumor, and additional radical surgery was performed in five others. One patient presented metastatic disease at the time of repeat surgery. The final pathology revealed residual/additional disease in all T2 tumors after radical surgery whereas the T1b patient underwent a salvage Whipple’s procedure due to a secondary distal cholangiocarcinoma. The patient with T1a tumor is alive after 3-year follow-up but all of the others died because of disease recurrence/progression up to 12 months.ConclusionThis study confirms the poor prognosis of Gallbladder cancer even when incidentally diagnosed following cholecystectomy and supposes a 3-year prevalence estimate of 0.34% for incidental gallbladder cancer in our Center from Pernambuco State, Brazil.

12 March 2018 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MMMario Martins
Mario Martins
RSRogério L. D. Santos
Rogério L. D. Santos
KJKleber D. N. Jatahy
Kleber D. N. Jatahy
MMMarina C. D. Matta
Marina C. D. Matta
TBThales P. Batista
Thales P. Batista
LTLeuridan C. Torres
Leuridan C. Torres